Home » Topics » Regulatory

Regulatory
RSS

Foscavir approved in Japan to treat HHV-6 encephalitis

March 27, 2019

AnGes obtains conditional approval in Japan for HGF plasmid in critical limb ischemia

March 27, 2019

Revcovi approved in Japan for ADA deficiency

March 27, 2019

FDA approves Mayzent for relapsing forms of MS

March 27, 2019

Vyndaqel approved in Japan for transthyretin amyloid cardiomyopathy

March 26, 2019

Japan first to approve Skyrizi for psoriasis indications

March 26, 2019

Smyraf approved in Japan to treat rheumatoid arthritis

March 26, 2019

European Commission approves Forxiga for type 1 diabetes

March 25, 2019

FDA approves Sunosi for excessive daytime sleepiness associated with narcolepsy or OSA

March 21, 2019

FDA approves Zulresso for postpartum depression

March 20, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...
AI drug developer Insilico to raise $292 million in Hong Kong IPO
BioWorld
Insilico Medicine Inc. plans to raise HK$2.27 billion (US$292 million) in its IPO on the Hong Kong Securities Exchange to advance its clinical pipeline and invest...